- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ascentage Pharma Grp International (6855)
Ascentage Pharma Grp International stock price live, this page displays HK 6855 stock exchange data. View the 6855 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ascentage Pharma Grp International real time stock price chart below.
What Is the Ascentage Pharma Grp International Stock Price Today?
The Ascentage Pharma Grp International stock price today is 37.65.
What Is the Stock Symbol for Ascentage Pharma Grp International?
The stock symbol for Ascentage Pharma Grp International is "6855."
What Stock Exchange Does Ascentage Pharma Grp International Trade On?
Ascentage Pharma Grp International is listed and trades on the Hong Kong stock exchange.
Is Ascentage Pharma Grp International a Good Stock to Buy?
Determining whether Ascentage Pharma Grp International—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6855 quote. (ISIN: KYG0519B1023)
What Is the Ascentage Pharma Grp International Stock Price Today?
The Ascentage Pharma Grp International stock price today is 37.65.
What Is the Stock Symbol for Ascentage Pharma Grp International?
The stock symbol for Ascentage Pharma Grp International is "6855."
What Stock Exchange Does Ascentage Pharma Grp International Trade On?
Ascentage Pharma Grp International is listed and trades on the Hong Kong stock exchange.
Is Ascentage Pharma Grp International a Good Stock to Buy?
Determining whether Ascentage Pharma Grp International—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6855 quote. (ISIN: KYG0519B1023)
Hong Kong
Currency in HKD
37.65
+0.75(+2.03%)
Delayed Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37.20
38.25
52 wk Range
15.42
48.85
6855 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37.2038.25
52 wk Range
15.4248.85
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6855 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Analysts Sentiment
Strong Buy
Price Target
55.47
Upside
+47.32%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Ascentage Pharma Company Profile
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company’s primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor, and non-Hodgkin’s lymphoma. In addition, the company is developing APG-1387, a small molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection; APG-2449, an oral inhibitor of FAK, ROS1, and ALK kinases; APG-5918, an orally available and selective embryonic ectoderm development inhibitor; APG-265, a MDM2 protein degrader; and UBX1967/1325, which are Bcl-2 inhibitors. In addition, it is also involved in medical research and development; clinical development; clinical trial operation; venture capital investment; rental services; and science and technology promotion services. The company has collaboration relationships with biotechnology and pharmaceutical companies; and research institutions. Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China.
Compare 6855 to Peers and Sector
Metrics to compare | 6855 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6855PeersSector | |
|---|---|---|---|---|
P/E Ratio | −32.7x | −8.9x | −0.5x | |
PEG Ratio | −0.53 | −0.02 | 0.00 | |
Price/Book | 15.4x | 2.7x | 2.6x | |
Price / LTM Sales | 13.1x | 11.3x | 3.0x | |
Upside (Analyst Target) | 44.9% | 7.2% | 55.3% | |
Fair Value Upside | Unlock | 19.3% | 9.8% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 55.47
(+47.32% Upside)
FAQ
What Is the Ascentage Pharma (6855) Stock Price Today?
The Ascentage Pharma stock price today is 37.65.
What Stock Exchange Does Ascentage Pharma Trade On?
Ascentage Pharma is listed and trades on the Hong Kong stock exchange.
What Is the Stock Symbol for Ascentage Pharma?
The stock symbol for Ascentage Pharma is "6855."
What Is the Ascentage Pharma Market Cap?
As of today, Ascentage Pharma market cap is 12.64B.
What is Ascentage Pharma Earnings Per Share?
The Ascentage Pharma EPS is -1.24.
From a Technical Analysis Perspective, Is 6855 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.